Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes-Reference-Cited by-同舟云学术

Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes

Published:2022-05 Issue: Volume:345 Page:661-674
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Baldassi Domizia,Ambike Shubhankar,Feuerherd Martin,Cheng Cho-Chin,Peeler David J.,Feldmann Daniel P.,Porras-Gonzalez Diana Leidy,Wei Xin,Keller Lea-Adriana,Kneidinger Nikolaus,Stoleriu Mircea Gabriel,Popp Andreas,Burgstaller Gerald,Pun Suzie H.,Michler Thomas,Merkel Olivia M.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference59 articles.

1. Transmissibility and transmission of respiratory viruses;Leung;Nat. Rev. Microbiol.,2021

2. Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19;Bridges;Thorax.,2021

3. Clinical Characteristics of Coronavirus Disease 2019 in China;Guan;N. Engl. J. Med.,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 replication and drug discovery;Molecular and Cellular Probes;2024-10

2. Evaluation of the effect of RNA secondary structure on Cas13d-mediated target RNA cleavage;Molecular Therapy - Nucleic Acids;2024-09

3. Strategies and mechanisms for endosomal escape of therapeutic nucleic acids;Current Opinion in Chemical Biology;2024-08

4. Organotypic lung tissue culture as a preclinical model to study host- influenza A viral infection: A case for repurposing of nafamostat mesylate;Tissue and Cell;2024-04

5. Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA Delivery;Nano Letters;2024-03-04